2179.HK

Jiangsu Recbio Technology Co., Ltd.
HKSEHKDEQUITY DELAYED
Last price
5.00
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
5.00
Day high
5.01
Day low
5.01
Volume
5.00K
Market cap
P/E (TTM)
52W range
3.40 – 8.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-2.53% -1.4%
1M
-0.79% -4.1%
3M
-2.91% -5.3%
6M
+1.21% -10.7%
YTD
+25.00% +13.0%
1Y
-35.65% -55.8%
3Y
-59.81% -134.8%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on 2179.HK open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 3 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $12.73M$0$0$0
Operating revenue $12.73M$0$0$0
Cost of revenue $1.49M$0
Gross profit $11.23M$0
Research & development $520.70M$476.12M$487.85M$716.44M +9.4%
Selling, general & admin $92.95M$111.67M$152.24M$163.96M -16.8%
Total operating expense $597.68M$560.79M$609.71M$875.08M +6.6%
Operating income -$586.44M-$560.79M-$609.71M-$875.08M -4.6%
Net interest income -$21.15M$2.48M$32.01M$20.44M -952.6%
Pre-tax income -$608.23M-$561.90M-$572.44M-$736.00M -8.2%
Tax provision $2.16M$0$0$0
Net income -$610.39M-$562.39M-$571.96M-$722.70M -8.5%
Net income to common -$610.39M-$562.39M-$571.96M-$722.70M -8.5%
Basic EPS -1.15-1.16-1.19-1.52 +0.9%
Diluted EPS -1.15-1.16-1.19-1.52 +0.9%
EBIT -$584.27M-$543.00M-$558.88M-$732.46M -7.6%
EBITDA -$479.15M-$462.19M-$494.98M-$691.53M -3.7%
Basic shares 531.24M478.54M480.94M474.21M +11.0%
Diluted shares 531.24M478.54M480.94M474.21M +11.0%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
4.99
+0.12% from price
SMA 20
5.01
-0.18% from price
SMA 50
4.94
+1.13% from price
SMA 100
4.92
+1.63% from price
SMA 200
5.04
-0.83% from price
EMA 12
5.01
-0.24% from price
EMA 26
5.00
+0.02% from price
EMA 50
4.97
+0.60% from price
RSI (14)
50.3
Neutral
MACD (12,26,9)
0.01
Hist -0.00
ATR (14)
0.04
0.71% of price
Realised vol 30D
16.2%
Annualised
Bollinger upper
5.14
20, 2σ
Bollinger lower
4.88
20, 2σ
50 / 200 cross
Death
4.94 vs 5.04
Trend bias
Below 200
-0.83%

Options chain

Account required
Expiry
Spot 5.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.00
Less volatile than market
Correlation to SPY
-0.00
Largely independent
Realised vol 30D
16.2%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-56.3%
Peak to trough
Max drawdown 5Y
-87.6%
Peak to trough
ATR 14
0.04
0.71% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.